RAFAEL HOLDINGS, INC. Conversion of Stock, Shares Converted
RAFAEL HOLDINGS, INC. (RFL) reported Conversion of Stock, Shares Converted of 32.20 million shares for the 6-month period ending 2024-01-31, per its 10-Q filed 2024-03-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2024-03-14
- 2024-01-31: Conversion of Stock, Shares Converted 6 month 32.20M shares.
- 2019-12-31: Conversion of Stock, Shares Converted 1 month 2.12M shares.
- 2019-08-31: Conversion of Stock, Shares Converted 1 month 1.85M shares.
- 2019-01-31: Conversion of Stock, Shares Converted 6 month 8.70M shares.
| Period end | Conversion of Stock, Shares Converted 1 month | Conversion of Stock, Shares Converted 6 month |
|---|---|---|
| 2024-01-31 | 32.20M shares 10-Q · filed 2024-03-14 | |
| 2019-12-31 | 2.12M shares 10-K · filed 2021-10-18 | |
| 2019-08-31 | 1.85M shares 10-Q · filed 2019-12-09 | |
| 2019-01-31 | 8.70M shares 10-Q · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |